Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs3923353 | chr6:45256482 | C/G | 8.99E-5 | 175 | 16.37 | 15.93 | 12.2 | KM Plot |
| PAAD | rs397826 | chr5:94606669 | C/T | 2.17E-8 | 178 | 2.15 | 18.48 | 14.48 | KM Plot |
| PAAD | rs4076201 | chr15:81572303 | C/T | 4.53E-5 | 178 | 1.37 | 15.67 | 15.57 | KM Plot |
| PAAD | rs41268741 | chr1:227327502 | G/A | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs41268743 | chr1:227327527 | T/C | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
| PAAD | rs41270147 | chr1:227406908 | G/A | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
| PAAD | rs41303917 | chr20:36573839 | G/A | 5.36E-8 | 173 | 14.9 | 17.17 | 3.17 | KM Plot |
| PAAD | rs41521045 | chr2:217939336 | C/T | 2.59E-5 | 178 | 5.97 | 16.17 | 15.5 | KM Plot |
| PAAD | rs421754 | chr5:94606467 | T/A | 2.17E-8 | 178 | 2.15 | 18.48 | 14.48 | KM Plot |
| PAAD | rs4246269 | chr12:104707562 | C/T | 1.12E-12 | 176 | 1.37 | 15.8 | 15.53 | KM Plot |
| PAAD | rs4246270 | chr12:104728530 | G/A | 1.12E-12 | 176 | 1.37 | 15.8 | 15.53 | KM Plot |
| PAAD | rs4246271 | chr12:104741525 | C/G | 8.28E-13 | 178 | 1.37 | 15.8 | 15.43 | KM Plot |
| PAAD | rs4265601 | chr11:125565781 | A/C | 4.48E-5 | 177 | 16.05 | 11.6 | 4.1 | KM Plot |
| PAAD | rs4278527 | chr11:125729400 | A/T | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
| PAAD | rs4290522 | chr17:6069442 | G/A | 8.39E-13 | 176 | 15.33 | 16.15 | 1.37 | KM Plot |